H. N. K. Alizai, A. Pasha, P. K. Alizai, and N. Zia, “The first approved drug for abnormal bone formation: palovarotene challenges and way forward”, J Pak Med Assoc, vol. 74, no. 06, pp. 940–942, Jun. 2025.